Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• LY4101174

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Solid Tumor, Recurrent Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING